385 related articles for article (PubMed ID: 9419338)
21. Suppressors of cytokine signaling (SOCS): negative regulators of signal transduction.
Alexander WS; Starr R; Metcalf D; Nicholson SE; Farley A; Elefanty AG; Brysha M; Kile BT; Richardson R; Baca M; Zhang JG; Willson TA; Viney EM; Sprigg NS; Rakar S; Corbin J; Mifsud S; DiRago L; Cary D; Nicola NA; Hilton DJ
J Leukoc Biol; 1999 Oct; 66(4):588-92. PubMed ID: 10534114
[TBL] [Abstract][Full Text] [Related]
22. SOCS proteins: negative regulators of cytokine signaling.
Krebs DL; Hilton DJ
Stem Cells; 2001; 19(5):378-87. PubMed ID: 11553846
[TBL] [Abstract][Full Text] [Related]
23. A new protein containing an SH2 domain that inhibits JAK kinases.
Endo TA; Masuhara M; Yokouchi M; Suzuki R; Sakamoto H; Mitsui K; Matsumoto A; Tanimura S; Ohtsubo M; Misawa H; Miyazaki T; Leonor N; Taniguchi T; Fujita T; Kanakura Y; Komiya S; Yoshimura A
Nature; 1997 Jun; 387(6636):921-4. PubMed ID: 9202126
[TBL] [Abstract][Full Text] [Related]
24. Distinct activities of suppressor of cytokine signaling (SOCS) proteins and involvement of the SOCS box in controlling G-CSF signaling.
van de Geijn GJ; Gits J; Touw IP
J Leukoc Biol; 2004 Jul; 76(1):237-44. PubMed ID: 15107455
[TBL] [Abstract][Full Text] [Related]
25. The SOCS proteins: a new family of negative regulators of signal transduction.
Nicholson SE; Hilton DJ
J Leukoc Biol; 1998 Jun; 63(6):665-8. PubMed ID: 9620657
[TBL] [Abstract][Full Text] [Related]
26. The SOCS box-adapting proteins for ubiquitination and proteasomal degradation.
Linossi EM; Nicholson SE
IUBMB Life; 2012 Apr; 64(4):316-23. PubMed ID: 22362562
[TBL] [Abstract][Full Text] [Related]
27. Interleukin 9 induces expression of three cytokine signal inhibitors: cytokine-inducible SH2-containing protein, suppressor of cytokine signalling (SOCS)-2 and SOCS-3, but only SOCS-3 overexpression suppresses interleukin 9 signalling.
Lejeune D; Demoulin JB; Renauld JC
Biochem J; 2001 Jan; 353(Pt 1):109-116. PubMed ID: 11115404
[TBL] [Abstract][Full Text] [Related]
28. Secondary structure assignment of mouse SOCS3 by NMR defines the domain boundaries and identifies an unstructured insertion in the SH2 domain.
Babon JJ; Yao S; DeSouza DP; Harrison CF; Fabri LJ; Liepinsh E; Scrofani SD; Baca M; Norton RS
FEBS J; 2005 Dec; 272(23):6120-30. PubMed ID: 16302975
[TBL] [Abstract][Full Text] [Related]
29. The CIS/SOCS proteins: a family of cytokine-inducible regulators of signaling.
Gisselbrecht S
Eur Cytokine Netw; 1999 Dec; 10(4):463-70. PubMed ID: 10586112
[TBL] [Abstract][Full Text] [Related]
30. A new high affinity binding site for suppressor of cytokine signaling-3 on the erythropoietin receptor.
Hörtner M; Nielsch U; Mayr LM; Heinrich PC; Haan S
Eur J Biochem; 2002 May; 269(10):2516-26. PubMed ID: 12027890
[TBL] [Abstract][Full Text] [Related]
31. PRL receptor-mediated effects in female mouse adipocytes: PRL induces suppressors of cytokine signaling expression and suppresses insulin-induced leptin production in adipocytes in vitro.
Ling C; Billig H
Endocrinology; 2001 Nov; 142(11):4880-90. PubMed ID: 11606456
[TBL] [Abstract][Full Text] [Related]
32. Tissue-specific induction of SOCS gene expression by PRL.
Tam SP; Lau P; Djiane J; Hilton DJ; Waters MJ
Endocrinology; 2001 Nov; 142(11):5015-26. PubMed ID: 11606470
[TBL] [Abstract][Full Text] [Related]
33. Suppressor of cytokine signalling gene expression is elevated in breast carcinoma.
Raccurt M; Tam SP; Lau P; Mertani HC; Lambert A; Garcia-Caballero T; Li H; Brown RJ; McGuckin MA; Morel G; Waters MJ
Br J Cancer; 2003 Aug; 89(3):524-32. PubMed ID: 12888825
[TBL] [Abstract][Full Text] [Related]
34. Negative regulation of cytokine signaling pathways.
Yasukawa H; Sasaki A; Yoshimura A
Annu Rev Immunol; 2000; 18():143-64. PubMed ID: 10837055
[TBL] [Abstract][Full Text] [Related]
35. Negative regulation of cytokine signaling by CIS/SOCS family proteins and their roles in inflammatory diseases.
Hanada T; Kinjyo I; Inagaki-Ohara K; Yoshimura A
Rev Physiol Biochem Pharmacol; 2003; 149():72-86. PubMed ID: 12687406
[TBL] [Abstract][Full Text] [Related]
36. Inhibitors keep cytokines in check.
Kovanen PE; Leonard WJ
Curr Biol; 1999 Dec; 9(23):R899-902. PubMed ID: 10607559
[TBL] [Abstract][Full Text] [Related]
37. The SOCS box: a tale of destruction and degradation.
Kile BT; Schulman BA; Alexander WS; Nicola NA; Martin HM; Hilton DJ
Trends Biochem Sci; 2002 May; 27(5):235-41. PubMed ID: 12076535
[TBL] [Abstract][Full Text] [Related]
38. Mechanism of inhibition of growth hormone receptor signaling by suppressor of cytokine signaling proteins.
Hansen JA; Lindberg K; Hilton DJ; Nielsen JH; Billestrup N
Mol Endocrinol; 1999 Nov; 13(11):1832-43. PubMed ID: 10551777
[TBL] [Abstract][Full Text] [Related]
39. Regulatory effect of SOCS on NF-kappaB activity in murine monocytes/macrophages.
Park SH; Kim KE; Hwang HY; Kim TY
DNA Cell Biol; 2003 Feb; 22(2):131-9. PubMed ID: 12713738
[TBL] [Abstract][Full Text] [Related]
40. Ankyrin repeat and suppressors of cytokine signaling box protein asb-9 targets creatine kinase B for degradation.
Debrincat MA; Zhang JG; Willson TA; Silke J; Connolly LM; Simpson RJ; Alexander WS; Nicola NA; Kile BT; Hilton DJ
J Biol Chem; 2007 Feb; 282(7):4728-4737. PubMed ID: 17148442
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
